Sanaria and UMBI Win SBIR Grant for Malaria Research
Posted on: Wednesday, 30 July 2008, 12:01 CDT
Sanaria and the University of Maryland Biotechnology Institute have received a multi-year small business innovation research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
The small business innovation research (SBIR) grant will support research and development efforts to genetically engineer mosquitoes that can enhance Sanaria's whole-parasite malaria vaccine production process.
David O'Brochta, director of the Insect Transformation Facility at University of Maryland Biotechnology (UMBI), said: "The partnership between Sanaria and UMBI supported by this SBIR grant is an ideal example of public-private partnership in the development of groundbreaking technology.
"It presents an extraordinary opportunity to exploit the capabilities of our Insect Transformation Facility in pursuit of a goal of enormous biomedical importance."
Source: Datamonitor
Related Articles
- Carnegie Mellon Researchers Receive Grant
- Researcher Gets Grant to Fight Diabetes
- Acclarent Establishes Research Training Grant Program Fostering Innovative Research
- Juvaris BioTherapeutics Announces Award of Small Business Innovation Research (SBIR) Grant for Pathogen Countermeasure Development
- Researchers Receive Grant for New Bird Flu Drug
- ProlX Pharmaceuticals Corp. Awarded $4.5 Million in Small Business Innovation Research (SBIR) Grants By the NIH
- Coalition Seeks Research Proposals: Grants Available for Diabetes, Obesity Projects
- NASA Awards Florida Research Science Grant
- ProlX Pharmaceuticals Corp. Awarded Four Small Business Innovation Research (SBIR) Grants By the NIH
- Researchers Get Grant for Vaccine Study
 |
 |
User Comments (0)
RSS Feeds